Ocular TGF-β, Matrix Metalloproteinases, and TIMP-1 Increase with the Development and Progression of Diabetic Retinopathy in Type 2 Diabetes Mellitus

Ocular TGF-β, Matrix Metalloproteinases, and TIMP-1 Increase with the Development and Progression of Diabetic Retinopathy in Type 2 Diabetes Mellitus

Diabetic retinopathy (DR) is a sight-threatening late complication of diabetes mellitus (DM). Even though its pathophysiology has not been fully elucidated, several studies suggested a role for transforming growth factor- (TGF-) β, matrix metalloproteinases (MMPs), and tissue inhibitors of matrix me...

Full description

Bibliographic Details
Main Authors:	Lucia Saucedo, Isabel B. Pfister, Souska Zandi, Christin Gerhardt, Justus G. Garweg
Format:	Article
Language:	English
Published:	Hindawi Limited 2021-01-01
Series:	Mediators of Inflammation
Online Access:	http://dx.doi.org/10.1155/2021/9811361

Similar Items

Visual Outcome after Intravitreal Anti-VEGF Therapy for Macular Neovascularisation Secondary to Sorsby’s Fundus Dystrophy: A Systematic Review
by: Arthur Baston, et al.
Published: (2021-05-01)

Cytokine profiles in the aqueous humor and serum of patients with dry and treated wet age-related macular degeneration.
by: Jan Spindler, et al.
Published: (2018-01-01)

Comparison of cytokine profiles in the aqueous humor of eyes with pseudoexfoliation syndrome and glaucoma.
by: Justus G Garweg, et al.
Published: (2017-01-01)

Molecular basis of the inhibition of matrix metalloproteinases (MMPs) by the tissue inhibitors of metalloproteinases (TIMPs)
by: Rapti, Magdalini
Published: (2004)

The regulation of tissue inhibitors of Matrix metalloproteinases (TIMPs) in the gastric epothelium
by: Michael, Angharad Wyn
Published: (2008)

COMBINATIONS OF CYTOKINE AND MATRIX METALLOPROTEINASE GENES ASSOCIATED WITH RETINOPATHY IN TYPE 2 DIABETIC WOMEN
by: V. I. Konenkov, et al.
Published: (2015-12-01)

Combinations of cytokine and matrix metalloproteinase genes associated with retinopathy in type 2 diabetic women
by: V.I. Konenkov,, et al.
Published: (2013-04-01)

Matrix metalloproteinase MMP-2 and MMP-9 and their inhibitors TIMP-1 and TIMP-2 in bladder carcinoma
by: Vasala, K. (Kaija)
Published: (2008)

Urine Levels of Matrix Metalloproteinases and Tissue Inhibitor of Metalloproteinases in Children with Type 1 Diabetes Mellitus
by: Zeynep Yürük Yıldırım, et al.
Published: (2019-06-01)

Balance between matrix metalloproteinases (MMP) and tissue inhibitors of metalloproteinases (TIMP) in the cervical mucus plug estimated by determination of free non-complexed TIMP
by: Uldbjerg Niels, et al.
Published: (2008-09-01)

Matrix metalloproteinase-2 (MMP-2), MMP-9, tissue inhibitor of matrix metalloproteinases (TIMP-1) and transforming growth factor-β2 (TGF-β2) expression in eutopic endometrium of women with peritoneal endometriosis
by: Krzysztof Szymanowski, et al.
Published: (2016-09-01)

The role of matrix metalloproteinases (MMPs) and their inhibitors (TIMPs) in the development of esophageal cancer
by: Maciej Szmitkowski, et al.
Published: (2012-04-01)

miR-122 promotes diabetic retinopathy through targeting TIMP3
by: Mingliang Wang, et al.
Published: (2020-09-01)

Fibrogenesis and Carcinogenesis in Nonalcoholic Steatohepatitis (NASH): Involvement of Matrix Metalloproteinases (MMPs) and Tissue Inhibitors of Metalloproteinase (TIMPs)
by: Isao Okazaki, et al.
Published: (2014-06-01)

Association of matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 levels with diabetic foot ulcer in Egyptians with type 2 diabetes mellitus
by: Ghada H Sayed, et al.
Published: (2018-01-01)

Altered Matrix Metalloproteinases Expression in Placenta from Patients with Gestational Diabetes Mellitus
by: Rong Ding, et al.
Published: (2018-01-01)

Interaction between matrix metalloproteinases and interleukin-4 in type 2 diabetes mellitus
by: Yi-Ching, et al.
Published: (2006)

DIABETIC RETINOPATHY AT THE DIABETES MELLITUS TYPE 1
by: E. B. Balzhinimayev, et al.
Published: (2012-11-01)

Frequency and severity of diabetic retinopathy in non-ocular diabetic complications
by: Malekmadani M H, et al.
Published: (2007-09-01)

Expression of Matrix Metalloproteinases (MMPs) and Their Tissue Inhibitors (TIMPs) in Frozen Sperm of Rabbit
by: Sang Hwan Kim, et al.
Published: (2019-09-01)

The expression of matrix metalloproteinases (MMPs) and their inhibitors (TIMPs) in metastatic colorectal carcinoma (CRC)
by: Kelly, Stephen Richard
Published: (2003)

Relationship between vitreous levels of matrix metalloproteinases and vascular endothelial growth factor in proliferative diabetic retinopathy.
by: Ahmed M Abu El-Asrar, et al.
Published: (2013-01-01)

Matrix Metalloproteinases in Diabetic Kidney Disease
by: Nuria Garcia-Fernandez, et al.
Published: (2020-02-01)

Imbalances between matrix metalloproteinases (MMPs) and tissue inhibitor of metalloproteinases (TIMPs) in maternal serum during preterm labor.
by: Inge Tency, et al.
Published: (2012-01-01)

Diabetic retinopathy, visual impairment and ocular status among patients with diabetes mellitus in Yemen: A hospital-based study
by: Bamashmus Mahfouth, et al.
Published: (2009-01-01)

Enhanced cardiac expression of two isoforms of matrix metalloproteinase-2 in experimental diabetes mellitus.
by: Hye Won Lee, et al.
Published: (2019-01-01)

The Effect of Nano-Epigallocatechin-Gallate on Oxidative Stress and Matrix Metalloproteinases in Experimental Diabetes Mellitus
by: Adriana Elena Bulboaca, et al.
Published: (2020-02-01)

Frequency of diabetic retinopathy in patients with diabetes mellitus and its correlation with duration of diabetes mellitus
by: Piyush Bansal, et al.
Published: (2013-01-01)

Immunohistochemical characterization of the expression of matrix metalloproteinase - 9 (MMP-9) and tissue inhibitor of matrix metalloproteinase (TIMP-1) in the invasive endometrioid endometrial carcinoma
by: A. V. Chepets
Published: (2015-12-01)

The Effects of Scaling and Root Planing on the Systemic Levels of Matrix Metalloproteinase-9 (MMP-9) and Tissue Inhibitor of Matrix Metalloproteinase-1 (TIMP-1)
by: Nguyen, Khanh Vu Thuy
Published: (2007)

Immunopathology in ocular toxoplasmosis: facts and clues
by: Justus G Garweg, et al.
Published: (2009-03-01)

Expression of matrix metalloproteinases (MMP-1, MMP-2 and MMP-9) and their inhibitors (TIMP-1 and TIMP-2) in oral submucous fibrosis
by: Rajendran R, et al.
Published: (2006-01-01)

Expressions of Matrix Metalloproteinases (MMP-2, MMP-7, and MMP-9) and Their Inhibitors (TIMP-1, TIMP-2) in Inflammatory Bowel Diseases
by: Katarzyna Jakubowska, et al.
Published: (2016-01-01)

Matrix metalloproteinase-10/TIMP-2 structure and analyses define conserved core interactions and diverse exosite interactions in MMP/TIMP complexes.
by: Jyotica Batra, et al.
Published: (2013-01-01)

Matrix metalloproteinase MMP-8, TIMP-1 and MMP-8/TIMP-1 ratio in plasma in methicillin-sensitive Staphylococcus aureus bacteremia.
by: Erik Forsblom, et al.
Published: (2021-01-01)

Diabetic Retinopathy and Ocular Melanoma: How Far We Are?
by: Eliana B. Souto, et al.
Published: (2020-04-01)

Ocular Rigidity and Outflow Facility in Nonproliferative Diabetic Retinopathy
by: Theonitsa Panagiotoglou, et al.
Published: (2015-01-01)

The immunolocalization of the metalloproteinases and their inhibitor, TIMP, in cells and tissues
by: Hembry, Rosalind Marian
Published: (1991)

Correlation of the retinopathy degree with the change of ocular surface and corneal nerve in patients with type 2 diabetes mellitus
by: Jia-Xin Han, et al.
Published: (2021-05-01)

Matrix Metalloproteinase-1 and Matrix Metalloproteinase-9 in the Aqueous Humor of Diabetic Macular Edema Patients.
by: Jin-Woo Kwon, et al.
Published: (2016-01-01)

Cannot write session to /tmp/vufind_sessions/sess_v7g9bpf2bb5m5f8c7u5td37020